• Idoxuridine: From Viral Mechanism to Translation

  2026-08-23

  Idoxuridine, also known as 5-iodo-2'-deoxyuridine, remains a useful mechanistic probe for viral DNA synthesis. This thought-leadership perspective connects its nucleoside biology with translational assay design, product-handling strategy, and lessons from human-neuron pharmacology without overstating evidence across domains.

• Cy3 TSA Fluorescence System Kit for IHC and ISH

  2026-08-22

  The Cy3 TSA Fluorescence System Kit converts HRP activity into localized, high-density Cy3 deposition for sensitive IHC, ICC, and ISH. This workflow-focused guide explains how to apply a TSA fluorescence kit to low-abundance targets, spatial immune studies, and difficult tissue samples while controlling background and false-positive signal.

• Camostat Mesilate: Assay Logic Across Protease and PPI Biolo

  2026-08-22

  Camostat Mesilate is a trypsin-like protease inhibitor whose value depends on separating ENaC-linked, plasmin–TGF-β, and fibrosis readouts from viral protein–protein interaction assays. This guide translates structure-guided proteomimetic research into practical decisions for controls, endpoints, and mechanism-focused workflows.

• Dietary Arachidonic Acid and Humoral Immunity

  2026-08-21

  The reference study shows that dietary arachidonic acid can accelerate rabies vaccine-induced neutralizing antibody responses and improve protection in mice, with a related effect observed in human volunteers. Its central mechanistic contribution is linking lymph-node arachidonic acid metabolism to prostaglandin I2–cAMP–PKA signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.

• Radioiodinated Balsalazide for UC Imaging

  2026-08-20

  The reference study developed and evaluated radioiodinated balsalazide as a colon-associated tracer for imaging ulcerative colitis in mice. Its combination of optimized labeling, 24-hour stability testing, and comparative biodistribution provides a practical framework for inflammation research while leaving important questions about receptor specificity, disease-model generalizability, and clinical translation unresolved.

• TRIM66 and Monogenic Olfactory Receptor Expression

  2026-08-20

  This Nature Communications study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence surplus olfactory receptor genes. Genetic loss of Trim66 preserves low-level expression of multiple receptors, reduces overall receptor expression, and disrupts olfactory neural processing and innate behaviors, linking enhancer repression to sensory function.

• Cycloastragenol in Glucocorticoid-Induced Osteonecrosis

  2026-08-19

  This in vivo study shows that cycloastragenol limits femoral-head damage in a methylprednisolone-induced rat model of glucocorticoid-induced osteonecrosis. By combining micro-CT, angiography, histology, qPCR, and Western blotting, the work links structural preservation with reduced osteoclast activity and a lower RANKL-to-OPG signaling balance.

• Leucomycin (Kitasamycin) Assay Workflows

  2026-08-19

  Leucomycin, or kitasamycin, offers a practical macrolide model for bacterial growth inhibition assays, translational inhibition studies, and 23S rRNA resistance mapping. This guide converts evidence from a swine dysentery study into bench-ready workflows, comparative assay strategies, and troubleshooting decisions.

• Fangchinoline, TFEB, and Anti-H1N1 Lysosomal Defense

  2026-08-18

  The reference study identifies fangchinoline as a host-directed anti-influenza compound that restores TFEB-associated lysosomal biogenesis while disrupting endolysosomal trafficking required for H1N1 entry. Its combined use of Connectivity Map screening, transcriptomic analysis, lysosomal assays, time-resolved infection experiments, and in vivo validation provides a framework for studying lysosome-targeted antiviral mechanisms.

• iPSC Cardiomyocytes for Chemical Risk Characterization

  2026-08-18

  The reference study shows that combining concentration-response transcriptomics with functional testing in human iPSC-derived cardiomyocytes can improve chemical hazard prioritization and mechanistic interpretation. Across 464 chemicals, the integrated framework linked cardiomyocyte phenotypes, gene-expression changes, points of departure, and exposure information without relying on electrophysiology alone.

• AG-120 (Ivosidenib) Workflow for IDH1 Research

  2026-08-17

  Build a rigorous mutant-IDH1 workflow around AG-120 (Ivosidenib), linking 2-hydroxyglutarate reduction to proliferation, metabolism, and myeloid differentiation. The strategy also uses CD44 status and NADPH-linked readouts to distinguish target engagement from resistance or assay failure.

• Merimepodib (VX-497): IMPDH Inhibitor Guide

  2026-08-17

  Merimepodib, also known as VX-497, is a selective, noncompetitive, orally bioavailable IMPDH inhibitor. By limiting guanine nucleotide biosynthesis, it supports research on lymphocyte proliferation, immunosuppression, oncology, and host-directed antiviral mechanisms.

• NF-κB–Apaf1 Axis in Septic Acute Kidney Injury

  2026-08-16

  A 2026 study identifies an NF-κB/Apaf1/caspase-9 pathway that suppresses autophagy and promotes tubular apoptosis and inflammation during septic acute kidney injury. Genetic and pharmacological experiments position Apaf1 and caspase-9 as mechanistic links between inflammatory signaling, defective autophagy, and renal tubular damage, providing a framework for testing pathway-directed interventions.

• AG-221 (Enasidenib) in IDH2 AML Research

  2026-08-15

  AG-221 (Enasidenib) combines genotype-focused IDH2 inhibition with measurable 2-hydroxyglutarate reduction, making it useful for mechanism-led acute myeloid leukemia research. This guide shows how to connect metabolite, viability, differentiation, and CD44-metabolism readouts in a practical workflow while avoiding common assay failures.

• (-)-Blebbistatin for Mechanobiology Workflows

  2026-08-14

  (-)-Blebbistatin is a reversible, cell-permeable non-muscle myosin II inhibitor for separating actomyosin force generation from F-actin remodeling. This guide translates intermittent-stress mechanomemory findings into practical workflows for YAP translocation, cytoskeletal dynamics research, migration assays, and contractility studies.

8519 records 1/568 page Next 12345 下5页 Last page